Literature DB >> 12230982

Coordination of copper(II) ions by the 11-20 and 11-28 fragments of human and mouse beta-amyloid peptide.

Teresa Kowalik-Jankowska1, Monika Ruta-Dolejsz, Kornelia Wiśniewska, Leszek Lankiewicz.   

Abstract

A potentiometric and spectroscopic (UV-vis, CD and EPR) study of Cu(II) binding to the (11-20), (11-28), (Ac-11-20H) and (Ac-11-28) fragments of human (H) and mouse (M) beta-amyloid peptide was carried out. The values of the protonation constants of the two lysine side chain amino groups for the (11-28) and (Ac-11-28) fragments of beta-amyloid peptide differ noticeably suggesting considerable interactions between the two residues. The N-terminal amino acid sequence Xaa-Yaa-His for the (11-20H) and (11-28H) fragments determines the coordination ability of the fragments studied to copper(II) ions. Addition of the (17-20) and (17-28) sequences to the (11-16) fragment of human and mouse beta-amyloid peptide does not change the coordination mode, and the stabilities of the complexes formed are comparable to those of the (11-16) peptide, although 1N complexes of the (11-28) fragments are stabilized by about one order of magnitude compared to those of the (11-16) peptides. The (Ac-11-28) peptides form complexes with the same coordination mode as those for the (Ac-11-16) fragments. The stability of the complexes for the (Ac-11-28H) fragment is one or two orders of magnitude higher compared to those of the (Ac-11-16H) fragment. This stabilization may result from structural organization of a peptide in copper(II) complexes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230982     DOI: 10.1016/s0162-0134(02)00495-6

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  4 in total

1.  Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity.

Authors:  Jijun Dong; Jeffrey M Canfield; Anil K Mehta; Jacob E Shokes; Bo Tian; W Seth Childers; James A Simmons; Zixu Mao; Robert A Scott; Kurt Warncke; David G Lynn
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-08       Impact factor: 11.205

Review 2.  Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease.

Authors:  Garth J S Cooper
Journal:  Drugs       Date:  2011-07-09       Impact factor: 9.546

Review 3.  Applications of electron paramagnetic resonance to studies of neurological disease.

Authors:  John F Boas; Simon C Drew; Cyril C Curtain
Journal:  Eur Biophys J       Date:  2008-02-07       Impact factor: 1.733

4.  Copper accumulation and the effect of chelation treatment on cerebral amyloid angiopathy compared to parenchymal amyloid plaques.

Authors:  Xiayoue Zhu; Tiffany W Victor; Ashwin Ambi; Joseph K Sullivan; Joshua Hatfield; Feng Xu; Lisa M Miller; William E Van Nostrand
Journal:  Metallomics       Date:  2020-02-27       Impact factor: 4.526

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.